Vascularization index of | Measurement plane/lobe | Graves disease subgroups | Graves disease ( |
Control group ( |
|
---|---|---|---|---|---|
New diagnosis ( |
Follow up ( |
||||
|
Transverse (T) | 15.2 (2.5-30) | 13 (2.9–41.2) | 13.2 (2.5-41.2) | 4.8 (0.7-10.1) |
Longitudinal (L) | 13 (1.35-29.2) | 11.6 (0.7-32.8) | 11.8 (0.7-32.8) | 5.8 (1.6-12) | |
(T+L)/2 | 13.3 (3.1-29.6) | 12.3 (3-35.05) | 12.4 (3-35.05) | 5.15 (1.75-9.65) | |
|
Transverse | 9.5 (4.6-25) | 12.1 (1.5-29.1) | 12.1 (1.5-29.1) | 4.8 (0.8-10) |
Longitudinal | 12.6 (4.9-31.3) | 9.9 (1.7-29.4) | 11.5 (1.7-31.3) | 5.4 (0.3-15.6) | |
(T+L)/2 | 11.4 (5.2-28.5) | 11.2 (1.6-29.2) | 11.4 (1.6-29.2) | 5 (0.5-12.8) | |
|
(R+L)/2 | 13.05 (4.6-27.5) | 13.1 (2.95-35.1) | 13.05 (2.95-35.1) | 4.8 (0.75-10) |
|
(R+L)/2 | 11.2 (4.5-30.2) | 12.2 (1.2-29.1) | 11.95 (1.2-30.2) | 5.05 (1.55-11.7) |
|
(R+L)/2 | 11.9 (4.7-28.9) | 12.1 (2.3-32.1) | 12 (2.3-32.1) | 5.04 (1.1-10.8) |
Correlation analysis between |
|
Spearman’s rho | |
---|---|---|---|
|
|
0.001* | -0.426 |
|
0.018* | -0.270 | |
|
0.001* | 0.67 | |
|
0.28 | 0.179 | |
|
0.36 | -0.155 | |
|
0.004* | 0.327 | |
|
0.001* | 0.466 |
VI values | Cutoff value | Sensitivity, % | Specificity, % | AUC | 95% Confidence interval | |
---|---|---|---|---|---|---|
Lower bound | Upper bound | |||||
Transverse average | 6.3 | 83.8 | 82.5 | 0.872 | 0.786 | 0.958 |
Longitudinal average | 7.25 | 78.4 | 75 | 0.852 | 0.761 | 0.944 |
Total thyroid | 6.3 | 83.8 | 70 | 0.872 | 0.785 | 0.958 |
Comparison of VI values |
|
|
---|---|---|
Right transverse | Right longitudinal | 0.61 |
Left transverse | Left longitudinal | 0.96 |
Right transverse | Left transverse | 0.28 |
Right longitudinal | Left longitudinal | 0.25 |
Right average | Total thyroid | 0.14 |
Left average | Total thyroid | 0.13 |
Right average | Left average | 0.14 |
Transverse average | Longitudinal average | 0.67 |
Transverse average | Total thyroid | 0.6 |
Longitudinal average | Total thyroid | 0.67 |
Variables | Graves disease subgroups | Graves disease ( |
Control group ( |
||
---|---|---|---|---|---|
New diagnosis ( |
Follow up ( |
||||
|
2 M / 9 F | 8 M / 18 F | 10 M / 27 F | 11 M / 29 F | |
|
37.7 ± 8.7 | 41.4 ± 10.9 | 40.3 ± 10.3 | 40.9 ± 11.5 | |
|
4.4 (3-12) | 4.2 (1.7-7.8) | 4.4 (1.7-12) | 3 (1.2-7.3) | |
|
|
12.4 (4.5-31.1) | 9 (4.4-32.6) | 10.3 (4.4-32.6) | 5.8 (2.5-23.4) |
|
11.1 (2.2-21.3) | 7.3 (3-46.5) | 8.5 (2.2–46.5) | 5.6 (2.8-17.8) | |
|
23 (6.7-50.8) | 16.2 (7.4-79.1) | 19.4 (6.7-79.1) | 11.5 (5.3-31.2) | |
|
|
0.01 (0.01-0.18) | 1.07 (0.01-4.67) | 0.12 (0.01–4.67) | 2.24 (0.56-4.14) |
|
2.2 (0.88-7.47) | 1.16 (0.89-3.04) | 1.23 (0.88-7.47) | 3.27 (2.67–4.1) | |
|
6.2 (2.76-28.1) | 3.37 (2.59-11.2) | 3.63 (2.59-28.1) | 1.28 (0.9-1.69) | |
|
|
91.3 (11.7-600) | 110 (10-600) | 108.4 (10-600) | - |
|
47 (21.6-591) | 89.2 (10.9-1478) | 78.6 (10.9-1478) | - |
Echogenicity of thyroid parenchyma | GD group ( |
VI values of total thyroid Median (min–max) |
---|---|---|
|
7 (18.9%) | 12.26 (5.7-32.1) |
|
20 (54.1%) | 10.75 (2.3-22.8) |
|
10 (27%) | 16.77 (4.5-28.9) |